InfuSystem (NYSE:INFU) Upgraded at Roth Capital

InfuSystem (NYSE:INFU - Get Free Report) was upgraded by research analysts at Roth Capital to a "strong-buy" rating in a note issued to investors on Monday,Zacks.com reports.

INFU has been the topic of a number of other research reports. B. Riley upgraded InfuSystem to a "strong-buy" rating in a research note on Thursday, May 8th. Wall Street Zen lowered InfuSystem from a "strong-buy" rating to a "buy" rating in a report on Wednesday, May 14th.

InfuSystem Trading Up 4.4%

Shares of INFU opened at $5.75 on Monday. The business's 50-day moving average price is $5.95 and its 200 day moving average price is $6.34. The stock has a market capitalization of $120.84 million, a P/E ratio of 95.85 and a beta of 1.81. InfuSystem has a 1-year low of $4.61 and a 1-year high of $9.97. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50.

Hedge Funds Weigh In On InfuSystem

Several institutional investors have recently modified their holdings of INFU. Nuveen Asset Management LLC raised its holdings in InfuSystem by 14.1% during the fourth quarter. Nuveen Asset Management LLC now owns 86,379 shares of the company's stock worth $730,000 after acquiring an additional 10,647 shares in the last quarter. BNP Paribas Financial Markets grew its holdings in InfuSystem by 67.9% during the fourth quarter. BNP Paribas Financial Markets now owns 6,844 shares of the company's stock worth $58,000 after purchasing an additional 2,768 shares during the period. Deutsche Bank AG grew its holdings in InfuSystem by 148.3% during the fourth quarter. Deutsche Bank AG now owns 27,671 shares of the company's stock worth $234,000 after purchasing an additional 16,526 shares during the period. Two Sigma Investments LP grew its holdings in InfuSystem by 40.4% during the fourth quarter. Two Sigma Investments LP now owns 36,252 shares of the company's stock worth $306,000 after purchasing an additional 10,427 shares during the period. Finally, Northern Trust Corp grew its holdings in InfuSystem by 7.7% during the fourth quarter. Northern Trust Corp now owns 186,741 shares of the company's stock worth $1,578,000 after purchasing an additional 13,333 shares during the period. Institutional investors own 71.13% of the company's stock.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.